Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 63 entries
Sorted by: Best Match Show Resources per page
A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection.

Hepatobiliary surgery and nutrition

Jiao LR, Hakim DN, Gall TM, Fajardo A, Pencavel TD, Fan R, Sodergren MH.
PMID: 27500150
Hepatobiliary Surg Nutr. 2016 Aug;5(4):382-7. doi: 10.21037/hbsn.2016.05.02.

In order to induce liver hypertrophy to enable liver resection in patients with a small future liver remnant (FLR), various methods have been proposed in addition to portal vein embolisation (PVE). Most recently, the associating liver partition and portal...

Cite
Jiao LR, Hakim DN, Gall TM, et al. A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection. Hepatobiliary Surg Nutr. 2016;5(4):382-7doi: 10.21037/hbsn.2016.05.02.
Jiao, L. R., Hakim, D. N., Gall, T. M., Fajardo, A., Pencavel, T. D., Fan, R., & Sodergren, M. H. (2016). A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection. Hepatobiliary surgery and nutrition, 5(4), 382-7. https://doi.org/10.21037/hbsn.2016.05.02
Jiao, Long R, et al. "A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection." Hepatobiliary surgery and nutrition vol. 5,4 (2016): 382-7. doi: https://doi.org/10.21037/hbsn.2016.05.02
Jiao LR, Hakim DN, Gall TM, Fajardo A, Pencavel TD, Fan R, Sodergren MH. A totally laparoscopic associating liver partition and portal vein ligation for staged hepatectomy assisted with radiofrequency (radiofrequency assisted liver partition with portal vein ligation) for staged liver resection. Hepatobiliary Surg Nutr. 2016 Aug;5(4):382-7. doi: 10.21037/hbsn.2016.05.02. PMID: 27500150; PMCID: PMC4960415.
Copy Download .nbib Format: NLM
Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor.

Nature

Schnadt J, Brühwiler PA, Patthey L, O'Shea JN, Södergren S, Odelius M, Ahuja R, Karis O, Bässler M, Persson P, Siegbahn H, Lunell S, Mårtensson N.
PMID: 12167856
Nature. 2002 Aug 08;418(6898):620-3. doi: 10.1038/nature00952.

The ultrafast timescale of electron transfer processes is crucial to their role in many biological systems and technological devices. In dye-sensitized solar cells, the electron transfer from photo-excited dye molecules to nanostructured semiconductor substrates needs to be sufficiently fast...

Cite
Schnadt J, Brühwiler PA, Patthey L, et al. Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor. Nature. 2002;418(6898):620-3doi: 10.1038/nature00952.
Schnadt, J., Brühwiler, P. A., Patthey, L., O'Shea, J. N., Södergren, S., Odelius, M., Ahuja, R., Karis, O., Bässler, M., Persson, P., Siegbahn, H., Lunell, S., & Mårtensson, N. (2002). Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor. Nature, 418(6898), 620-3. https://doi.org/10.1038/nature00952
Schnadt, Joachim, et al. "Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor." Nature vol. 418,6898 (2002): 620-3. doi: https://doi.org/10.1038/nature00952
Schnadt J, Brühwiler PA, Patthey L, O'Shea JN, Södergren S, Odelius M, Ahuja R, Karis O, Bässler M, Persson P, Siegbahn H, Lunell S, Mårtensson N. Experimental evidence for sub-3-fs charge transfer from an aromatic adsorbate to a semiconductor. Nature. 2002 Aug 08;418(6898):620-3. doi: 10.1038/nature00952. PMID: 12167856.
Copy Download .nbib Format: NLM
Women with ovarian cancer described waiting for recurrence, facing the diagnosis of recurrence, managing treatment related concerns, and attempting to regain control.

Evidence-based nursing

Sodergren K.
PMID: 14577410
Evid Based Nurs. 2003 Oct;6(4):126-7.

No abstract available.

Cite
Sodergren K. Women with ovarian cancer described waiting for recurrence, facing the diagnosis of recurrence, managing treatment related concerns, and attempting to regain control. Evid Based Nurs. 2003;6(4):126-7
Sodergren, K. (2003). Women with ovarian cancer described waiting for recurrence, facing the diagnosis of recurrence, managing treatment related concerns, and attempting to regain control. Evidence-based nursing, 6(4), 126-7.
Sodergren, Kathleen. "Women with ovarian cancer described waiting for recurrence, facing the diagnosis of recurrence, managing treatment related concerns, and attempting to regain control." Evidence-based nursing vol. 6,4 (2003): 126-7.
Sodergren K. Women with ovarian cancer described waiting for recurrence, facing the diagnosis of recurrence, managing treatment related concerns, and attempting to regain control. Evid Based Nurs. 2003 Oct;6(4):126-7. PMID: 14577410.
Copy Download .nbib Format: NLM
A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique.

Cancers

Jayant K, Sodergren MH, Reccia I, Kusano T, Zacharoulis D, Spalding D, Pai M, Jiao LR, Huang KW.
PMID: 30413094
Cancers (Basel). 2018 Nov 08;10(11). doi: 10.3390/cancers10110428.

Liver cancer is the sixth most common cancer and third most common cause of cancer-related mortality. Presently, indications for liver resections for liver cancers are widening, but the response is varied owing to the multitude of factors including excess...

Cite
Jayant K, Sodergren MH, Reccia I, et al. A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique. Cancers (Basel). 2018;10(11)doi: 10.3390/cancers10110428.
Jayant, K., Sodergren, M. H., Reccia, I., Kusano, T., Zacharoulis, D., Spalding, D., Pai, M., Jiao, L. R., & Huang, K. W. (2018). A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique. Cancers, 10(11), . https://doi.org/10.3390/cancers10110428
Jayant, Kumar, et al. "A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique." Cancers vol. 10,11 (2018). doi: https://doi.org/10.3390/cancers10110428
Jayant K, Sodergren MH, Reccia I, Kusano T, Zacharoulis D, Spalding D, Pai M, Jiao LR, Huang KW. A Systematic Review and Meta-Analysis Comparing Liver Resection with the Rf-Based Device Habib™-4X with the Clamp-Crush Technique. Cancers (Basel). 2018 Nov 08;10(11). doi: 10.3390/cancers10110428. PMID: 30413094; PMCID: PMC6266432.
Copy Download .nbib Format: NLM
Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC.

Molecular therapy. Nucleic acids

Yoon S, Huang KW, Andrikakou P, Vasconcelos D, Swiderski P, Reebye V, Sodergren M, Habib N, Rossi JJ.
PMID: 31546149
Mol Ther Nucleic Acids. 2019 Dec 06;18:142-154. doi: 10.1016/j.omtn.2019.08.017. Epub 2019 Aug 22.

Pancreatic ductal adenocarcinoma (PDAC) is one of the most aggressive malignancies; it preferentially metastasizes to the liver and is the main cause of death from this disease. In previous studies, small activating RNA against CCAAT/enhancer-binding protein-α (C/EBPα-saRNA) demonstrated efficacy...

Cite
Yoon S, Huang KW, Andrikakou P, et al. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Mol Ther Nucleic Acids. 2019;18:142-154doi: 10.1016/j.omtn.2019.08.017.
Yoon, S., Huang, K. W., Andrikakou, P., Vasconcelos, D., Swiderski, P., Reebye, V., Sodergren, M., Habib, N., & Rossi, J. J. (2019). Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Molecular therapy. Nucleic acids, 18142-154. https://doi.org/10.1016/j.omtn.2019.08.017
Yoon, Sorah, et al. "Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC." Molecular therapy. Nucleic acids vol. 18 (2019): 142-154. doi: https://doi.org/10.1016/j.omtn.2019.08.017
Yoon S, Huang KW, Andrikakou P, Vasconcelos D, Swiderski P, Reebye V, Sodergren M, Habib N, Rossi JJ. Targeted Delivery of C/EBPα-saRNA by RNA Aptamers Shows Anti-tumor Effects in a Mouse Model of Advanced PDAC. Mol Ther Nucleic Acids. 2019 Dec 06;18:142-154. doi: 10.1016/j.omtn.2019.08.017. Epub 2019 Aug 22. PMID: 31546149; PMCID: PMC6796740.
Copy Download .nbib Format: NLM
The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis.

Cannabis and cannabinoid research

Hammond S, Erridge S, Mangal N, Pacchetti B, Sodergren MH.
PMID: 34664988
Cannabis Cannabinoid Res. 2021 Dec;6(6):474-487. doi: 10.1089/can.2021.0048. Epub 2021 Oct 18.

No abstract available.

Cite
Hammond S, Erridge S, Mangal N, et al. The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis. Cannabis Cannabinoid Res. 2021;6(6):474-487doi: 10.1089/can.2021.0048.
Hammond, S., Erridge, S., Mangal, N., Pacchetti, B., & Sodergren, M. H. (2021). The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis. Cannabis and cannabinoid research, 6(6), 474-487. https://doi.org/10.1089/can.2021.0048
Hammond, Samuel, et al. "The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis." Cannabis and cannabinoid research vol. 6,6 (2021): 474-487. doi: https://doi.org/10.1089/can.2021.0048
Hammond S, Erridge S, Mangal N, Pacchetti B, Sodergren MH. The Effect of Cannabis-Based Medicine in the Treatment of Cachexia: A Systematic Review and Meta-Analysis. Cannabis Cannabinoid Res. 2021 Dec;6(6):474-487. doi: 10.1089/can.2021.0048. Epub 2021 Oct 18. PMID: 34664988.
Copy Download .nbib Format: NLM
Microfluidic active pressure and flow stabiliser.

Scientific reports

Södergren S, Svensson K, Hjort K.
PMID: 34795333
Sci Rep. 2021 Nov 18;11(1):22504. doi: 10.1038/s41598-021-01865-4.

In microfluidics, a well-known challenge is to obtain reproducible results, often constrained by unstable pressures or flow rates. Today, there are existing stabilisers made for low-pressure microfluidics or high-pressure macrofluidics, often consisting of passive membranes, which cannot stabilise long-term...

Cite
Södergren S, Svensson K, Hjort K. Microfluidic active pressure and flow stabiliser. Sci Rep. 2021;11(1):22504doi: 10.1038/s41598-021-01865-4.
Södergren, S., Svensson, K., & Hjort, K. (2021). Microfluidic active pressure and flow stabiliser. Scientific reports, 11(1), 22504. https://doi.org/10.1038/s41598-021-01865-4
Södergren, Simon, et al. "Microfluidic active pressure and flow stabiliser." Scientific reports vol. 11,1 (2021): 22504. doi: https://doi.org/10.1038/s41598-021-01865-4
Södergren S, Svensson K, Hjort K. Microfluidic active pressure and flow stabiliser. Sci Rep. 2021 Nov 18;11(1):22504. doi: 10.1038/s41598-021-01865-4. PMID: 34795333; PMCID: PMC8602347.
Copy Download .nbib Format: NLM
Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol.

Cancers

den Hollander D, Fiore M, Martin-Broto J, Kasper B, Casado Herraez A, Kulis D, Nixon I, Sodergren SC, Eichler M, van Houdt WJ, Desar IME, Ray-Coquard I, Piccinin C, Kosela-Paterczyk H, Miah A, Hentschel L, Singer S, Wilson R, van der Graaf WTA, Husson O.
PMID: 33561018
Cancers (Basel). 2020 Dec 22;13(1). doi: 10.3390/cancers13010001.

Sarcomas comprise 1% of adult tumors and are very heterogeneous. Long-lasting and cumulative treatment side-effects detract from the (progression-free) survival benefit of treatment. Therefore, it is important to assess treatment effectiveness in terms of patient-reported outcomes (PROs), including health-related...

Cite
den Hollander D, Fiore M, Martin-Broto J, et al. Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol. Cancers (Basel). 2020;13(1)doi: 10.3390/cancers13010001.
den Hollander, D., Fiore, M., Martin-Broto, J., Kasper, B., Casado Herraez, A., Kulis, D., Nixon, I., Sodergren, S. C., Eichler, M., van Houdt, W. J., Desar, I. M. E., Ray-Coquard, I., Piccinin, C., Kosela-Paterczyk, H., Miah, A., Hentschel, L., Singer, S., Wilson, R., van der Graaf, W. T. A., & Husson, O. (2020). Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol. Cancers, 13(1), . https://doi.org/10.3390/cancers13010001
den Hollander, Dide, et al. "Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol." Cancers vol. 13,1 (2020). doi: https://doi.org/10.3390/cancers13010001
den Hollander D, Fiore M, Martin-Broto J, Kasper B, Casado Herraez A, Kulis D, Nixon I, Sodergren SC, Eichler M, van Houdt WJ, Desar IME, Ray-Coquard I, Piccinin C, Kosela-Paterczyk H, Miah A, Hentschel L, Singer S, Wilson R, van der Graaf WTA, Husson O. Incorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol. Cancers (Basel). 2020 Dec 22;13(1). doi: 10.3390/cancers13010001. PMID: 33561018; PMCID: PMC7792589.
Copy Download .nbib Format: NLM
UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes.

Journal of cannabis research

Nimalan D, Kawka M, Erridge S, Ergisi M, Harris M, Salazar O, Ali R, Loupasaki K, Holvey C, Coomber R, Platt M, Rucker JJ, Khan S, Sodergren MH.
PMID: 34980282
J Cannabis Res. 2022 Jan 04;4(1):3. doi: 10.1186/s42238-021-00114-9.

INTRODUCTION: Palliative care aims to improve quality of life through optimal symptom control and pain management. Cannabis-based medicinal products (CBMPs) have a proven role in the treatment of chemotherapy-induced nausea and vomiting. However, there is a paucity of high-quality...

Cite
Nimalan D, Kawka M, Erridge S, et al. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes. J Cannabis Res. 2022;4(1):3doi: 10.1186/s42238-021-00114-9.
Nimalan, D., Kawka, M., Erridge, S., Ergisi, M., Harris, M., Salazar, O., Ali, R., Loupasaki, K., Holvey, C., Coomber, R., Platt, M., Rucker, J. J., Khan, S., & Sodergren, M. H. (2022). UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes. Journal of cannabis research, 4(1), 3. https://doi.org/10.1186/s42238-021-00114-9
Nimalan, Devaki, et al. "UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes." Journal of cannabis research vol. 4,1 (2022): 3. doi: https://doi.org/10.1186/s42238-021-00114-9
Nimalan D, Kawka M, Erridge S, Ergisi M, Harris M, Salazar O, Ali R, Loupasaki K, Holvey C, Coomber R, Platt M, Rucker JJ, Khan S, Sodergren MH. UK Medical Cannabis Registry palliative care patients cohort: initial experience and outcomes. J Cannabis Res. 2022 Jan 04;4(1):3. doi: 10.1186/s42238-021-00114-9. PMID: 34980282; PMCID: PMC8725528.
Copy Download .nbib Format: NLM
The importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer.

Cancer

Husson O, Sodergren SC, Darlington AS.
PMID: 33496340
Cancer. 2021 May 15;127(10):1712-1713. doi: 10.1002/cncr.33416. Epub 2021 Jan 26.

No abstract available.

Cite
Husson O, Sodergren SC, Darlington AS. The importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer. Cancer. 2021;127(10):1712-1713doi: 10.1002/cncr.33416.
Husson, O., Sodergren, S. C., & Darlington, A. S. (2021). The importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer. Cancer, 127(10), 1712-1713. https://doi.org/10.1002/cncr.33416
Husson, Olga, et al. "The importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer." Cancer vol. 127,10 (2021): 1712-1713. doi: https://doi.org/10.1002/cncr.33416
Husson O, Sodergren SC, Darlington AS. The importance of a collaborative health-related quality of life measurement strategy for adolescents and young adults with cancer. Cancer. 2021 May 15;127(10):1712-1713. doi: 10.1002/cncr.33416. Epub 2021 Jan 26. PMID: 33496340.
Copy Download .nbib Format: NLM
Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry.

Journal of clinical pharmacology

Kawka M, Erridge S, Holvey C, Coomber R, Usmani A, Sajad M, Platt MW, Rucker JJ, Sodergren MH.
PMID: 34473850
J Clin Pharmacol. 2021 Dec;61(12):1545-1554. doi: 10.1002/jcph.1961. Epub 2021 Oct 05.

Cannabis-based medicinal products (CBMPs) are an emerging therapeutic option in the management of primary chronic pain, using the role of the endocannabinoid system in modulating central and peripheral pain processes. Despite promising preclinical data, there is a paucity of...

Cite
Kawka M, Erridge S, Holvey C, et al. Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry. J Clin Pharmacol. 2021;61(12):1545-1554doi: 10.1002/jcph.1961.
Kawka, M., Erridge, S., Holvey, C., Coomber, R., Usmani, A., Sajad, M., Platt, M. W., Rucker, J. J., & Sodergren, M. H. (2021). Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry. Journal of clinical pharmacology, 61(12), 1545-1554. https://doi.org/10.1002/jcph.1961
Kawka, Michal, et al. "Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry." Journal of clinical pharmacology vol. 61,12 (2021): 1545-1554. doi: https://doi.org/10.1002/jcph.1961
Kawka M, Erridge S, Holvey C, Coomber R, Usmani A, Sajad M, Platt MW, Rucker JJ, Sodergren MH. Clinical Outcome Data of First Cohort of Chronic Pain Patients Treated With Cannabis-Based Sublingual Oils in the United Kingdom: Analysis From the UK Medical Cannabis Registry. J Clin Pharmacol. 2021 Dec;61(12):1545-1554. doi: 10.1002/jcph.1961. Epub 2021 Oct 05. PMID: 34473850.
Copy Download .nbib Format: NLM
Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research

Hashimoto A, Sarker D, Reebye V, Jarvis S, Sodergren MH, Kossenkov A, Sanseviero E, Raulf N, Vasara J, Andrikakou P, Meyer T, Huang KW, Plummer R, Chee CE, Spalding D, Pai M, Khan S, Pinato DJ, Sharma R, Basu B, Palmer D, Ma YT, Evans J, Habib R, Martirosyan A, Elasri N, Reynaud A, Rossi JJ, Cobbold M, Habib NA, Gabrilovich DI.
PMID: 34407972
Clin Cancer Res. 2021 Nov 01;27(21):5961-5978. doi: 10.1158/1078-0432.CCR-21-0986. Epub 2021 Aug 18.

PURPOSE: To evaluate the mechanisms of how therapeutic upregulation of the transcription factor, CCAAT/enhancer-binding protein alpha (C/EBPα), prevents tumor progression in patients with advanced hepatocellular carcinoma (HCC) and in different mouse tumor models.EXPERIMENTAL DESIGN: We conducted a phase I...

Cite
Hashimoto A, Sarker D, Reebye V, et al. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. Clin Cancer Res. 2021;27(21):5961-5978doi: 10.1158/1078-0432.CCR-21-0986.
Hashimoto, A., Sarker, D., Reebye, V., Jarvis, S., Sodergren, M. H., Kossenkov, A., Sanseviero, E., Raulf, N., Vasara, J., Andrikakou, P., Meyer, T., Huang, K. W., Plummer, R., Chee, C. E., Spalding, D., Pai, M., Khan, S., Pinato, D. J., Sharma, R., Basu, B., Palmer, D., Ma, Y. T., Evans, J., Habib, R., Martirosyan, A., Elasri, N., Reynaud, A., Rossi, J. J., Cobbold, M., Habib, N. A., & Gabrilovich, D. I. (2021). Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 27(21), 5961-5978. https://doi.org/10.1158/1078-0432.CCR-21-0986
Hashimoto, Ayumi, et al. "Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer." Clinical cancer research : an official journal of the American Association for Cancer Research vol. 27,21 (2021): 5961-5978. doi: https://doi.org/10.1158/1078-0432.CCR-21-0986
Hashimoto A, Sarker D, Reebye V, Jarvis S, Sodergren MH, Kossenkov A, Sanseviero E, Raulf N, Vasara J, Andrikakou P, Meyer T, Huang KW, Plummer R, Chee CE, Spalding D, Pai M, Khan S, Pinato DJ, Sharma R, Basu B, Palmer D, Ma YT, Evans J, Habib R, Martirosyan A, Elasri N, Reynaud A, Rossi JJ, Cobbold M, Habib NA, Gabrilovich DI. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer. Clin Cancer Res. 2021 Nov 01;27(21):5961-5978. doi: 10.1158/1078-0432.CCR-21-0986. Epub 2021 Aug 18. PMID: 34407972.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 63 entries